Bellevue Life Sciences Acquisition's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Bellevue Life Sciences Acquisition (BLAC) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Bellevue Life Sciences Acquisition vs Its Competitors
- TTM: Trailing 12-month revenue of 2M vs -M combined for its competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-30.2% annualized vs trailing 12 months).
- Peer revenue share: Bellevue Life Sciences Acquisition accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
BLAC Sales vs. its Competitors, Q2 2026
Bellevue Life Sciences Acquisition generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
API endpoints for this dataset
For context: the Medical Equipment & Supplies industry grew revenue 14.4% year over year, combined, vs -69.4% for Bellevue Life Sciences Acquisition. Bellevue Life Sciences Acquisition's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
BLAC Stock Performance relative to its Competitors
Bellevue Life Sciences Acquisition's Comment on Competition and Industry Peers
Bellevue Life Sciences Acquisition's Competitors Named by the Company
Competitive relationships identified from Bellevue Life Sciences Acquisition reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Asahi Intecc | Company report | 85% |
| RMC | Company report | 85% |
Company report basis, confidence, active dates and source counts for Bellevue Life Sciences Acquisition's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
